Janus Henderson Group PLC Edgewise Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,558,519 shares of EWTX stock, worth $152 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

4,558,519

Previous 2,607,299 74.84%

Holding current value

$152 Million

Previous $47 Million 159.1%

% of portfolio

0.06%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$15.88 - $29.5 $31 Million - $57.6 Million	1,951,220 Added 74.84%	4,558,519 $122 Million
Q2 2024 Aug 14, 2024	BUY	$15.08 - $21.23 $12.1 Million - $17 Million	801,987 Added 44.42%	2,607,299 $47 Million
Q1 2024 May 15, 2024	BUY	$9.25 - $19.97 $5.46 Million - $11.8 Million	590,299 Added 48.58%	1,805,312 $32.9 Million
Q4 2023 Feb 14, 2024	BUY	$5.51 - $12.1 $519,295 - $1.14 Million	94,246 Added 8.41%	1,215,013 $13.3 Million
Q3 2023 Nov 14, 2023	BUY	$5.73 - $7.69 $3.09 Million - $4.15 Million	540,019 Added 92.99%	1,120,767 $6.42 Million
Q2 2023 Aug 14, 2023	SELL	$5.71 - $10.29 $1.08 Million - $1.95 Million	-189,051 Reduced 24.56%	580,748 $4.5 Million
Q1 2023 May 15, 2023	SELL	$6.66 - $11.33 $4.33 Million - $7.37 Million	-650,070 Reduced 45.78%	769,799 $5.13 Million
Q4 2022 Feb 14, 2023	SELL	$7.58 - $11.08 $933,378 - $1.36 Million	-123,137 Reduced 7.98%	1,419,869 $12.7 Million
Q3 2022 Nov 14, 2022	SELL	$8.08 - $13.58 $536,156 - $901,114	-66,356 Reduced 4.12%	1,543,006 $15.2 Million
Q2 2022 Aug 15, 2022	BUY	$5.67 - $9.87 $998,180 - $1.74 Million	176,046 Added 12.28%	1,609,362 $12.8 Million
Q1 2022 May 16, 2022	SELL	$9.1 - $18.97 $846,472 - $1.76 Million	-93,019 Reduced 6.09%	1,433,316 $13.9 Million
Q4 2021 Feb 14, 2022	SELL	$14.41 - $22.41 $2.96 Million - $4.61 Million	-205,688 Reduced 11.88%	1,526,335 $23.3 Million
Q3 2021 Nov 16, 2021	SELL	$14.11 - $24.1 $807,896 - $1.38 Million	-57,257 Reduced 3.2%	1,732,023 $27.6 Million
Q2 2021 Aug 16, 2021	SELL	$21.33 - $30.25 $7.5 Million - $10.6 Million	-351,628 Reduced 16.42%	1,789,280 $36.7 Million
Q1 2021 May 17, 2021	BUY	$30.0 - $35.99 $64.2 Million - $77.1 Million	2,140,908 New	2,140,908 $65.1 Million

Others Institutions Holding EWTX

# of Institutions

163

Shares Held

97.8M

Call Options Held

45.7K

Put Options Held

13.1K

View Full List

About Edgewise Therapeutics, Inc.

Ticker EWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,171,700
Market Cap $2.1B
Description
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...

More about EWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Edgewise Therapeutics, Inc. Transaction History